Fetal alcohol spectrum disorders and fetal alcohol syndrome: the state of the art and new diagnostic tools
References (22)
- et al.
Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol
Forensic Sci Int
(2010) - et al.
Determination of maternal–fetal biomarkers of prenatal exposure to ethanol: A review
J Pharm Biomed Anal
(2012) - et al.
Neonatal screening for prenatal alcohol exposure: Assessment of voluntary maternal participation in an open meconium screening program
Alcohol
(2012) - et al.
Vitamin A, folate, and choline as a possible preventive intervention to fetal alcohol syndrome
Med Hypotheses
(2012) - et al.
Fetal alcohol syndrome: new perspetives for an ancient and underestimated problem
J Matern Fetal Neonatal Med
(2011) - et al.
Population baseline of meconium ethyl glucuronide and ethyl sulfate concentrations in newborns of nondrinking women in 2 mediterranean cohorts
Ther Drug Monit
(2010) - et al.
Development of Canadian screening tools for fetal alcohol spectrum disorder
Can J Clin Pharmacol
(2008) - et al.
Epidemiology of FASD in a province in Italy: prevalence and characteristics of children in a random sample of schools
Alcohol Clin Exp Res
(2006) - et al.
Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis
CMAJ
(2005) - et al.
Automated diagnosis of fetal alcohol syndrome using 3D facial image analysis
Orthod Craniofac Res
(2008)
Liquid chromatography with tandem mass spectrometric detection for the measurement of ethyl glucuronide and ethyl sulfate in meconium: new biomarkers of gestational ethanol exposure?
Ther Drug Monit
Cited by (61)
Clinical features and risk factors associated with prenatal exposure to drugs of abuse
2021, Anales de PediatriaSingle leg hopping in children with fetal alcohol spectrum disorder: Dynamic postural stability and kinematics
2020, Journal of Bodywork and Movement TherapiesMeconium analysis as a promising diagnostic tool for monitoring fetal exposure to toxic substances: Recent trends and perspectives
2018, TrAC - Trends in Analytical ChemistryCitation Excerpt :Currently, it is very difficult to precisely estimate the prevalence of FAS and FASD, because there are no worldwide data available regarding this issue. However, it has been determined that the smallest prevalence of disorders associated with alcohol consumption during pregnancy is in the USA, where FAS is diagnosed in 0.5–2.0 per 1000 live infants, and in Canada, where FAS and FASD are observed in 1–3 and 9 per 1000 live births, respectively [17]. A worse situation is found in Europe.
Is post exposure prevention of teratogenic damage possible: Studies on diabetes, valproic acid, alcohol and anti folates in pregnancy: Animal studies with reflection to human
2018, Reproductive ToxicologyCitation Excerpt :Alcohol-induced birth defects are a major cause of teratogenesis [129]. Symptoms of fetal alcohol spectrum disorders (FASD) include unique facial features, neurocognitive defects, growth retardation (low weight and height), central nervous symptoms abnormalities manifested by cognitive and behavioral abnormalities [129,130]. The most recent research suggests that the prevalence of fetal alcohol spectrum disorder in the US ranges from 31.1 to 98.5 per 1000 children [131].
Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy
2018, AlcoholCitation Excerpt :Despite public health efforts to eliminate or reduce the consumption of tobacco and alcohol during pregnancy, recent international studies indicate that a significant number of pregnant women continue to consume tobacco and a high number of alcoholic beverages during gestation, worldwide (Blanquet, Leger, Gerbaud, & Vendittelli, 2016; Mårdby, Lupattelli, Hensing, & Nordeng, 2017; Pichini, Busardò, Ceccanti, Tarani, & Pacifici, 2017). Whereas prenatal exposure to tobacco can cause reversible transient alterations in exposed newborns, this is not the case of prenatal exposure to ethyl alcohol, which causes permanent disabilities (Crighton et al., 2016; Memo et al., 2013). The results of our study illustrate the importance of using objective measures to document tobacco and alcohol consumption during gestation and to disclose the real proportion of the phenomenon; this is in agreement with the study of Shisler et al. (2017), which considers more intensive prospective self-reporting measures and biological assays as a viable and superior alternative to single item self-report measures.